BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...
Haemonetics' strong hospital services growth and innovative products are promising, but regional headwinds, declining plasma revenue, and high debt levels warrant a Hold rating. The company saw a 9% ...
BOSTON, March 5, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical products and solutions to drive better patient ...
BOSTON, Dec. 12, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has ...
StockStory.org on MSN
Reflecting on medical devices & supplies - specialty stocks’ Q3 earnings: Haemonetics (NYSE:HAE)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, ...
Blood products company Haemonetics (NYSE:HAE). will be reporting results tomorrow before market open. Here’s what you need to know. Haemonetics missed analysts’ revenue expectations by 1.3% last ...
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Haemonetics (HAE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Petusky from Barrington remains neutral on the stock and has a $105.00 ...
BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results